Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Duncan Barbara Gayle Create: Alert

All | News | Filings
Date FiledTypeDescription
05/09/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.5, valued at $37.5k
02/07/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 1,188 shares @ $0
02/06/2023 3 Duncan Barbara Gayle (Director) has filed a Form 3 on HALOZYME THERAPEUTICS, INC.
07/01/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 500,000 options to buy @ $0
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 17,000 options to buy @ $3.6, valued at $61.2k
06/21/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 61,264 options to buy @ $6.5, valued at $398.2k
04/12/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 21,347 options to buy @ $3.22, valued at $68.7k
02/04/2022 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $2.72, valued at $40.8k
07/02/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 379,788 options to buy @ $0
06/22/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 15,700 options to buy @ $7.27, valued at $114.1k
06/21/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 34,025 options to buy @ $23.39, valued at $795.8k
06/11/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 15,000 options to buy @ $4.49, valued at $67.4k
06/07/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 17,000 options to buy @ $8.15, valued at $138.6k
05/18/2021 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 1,750 options to buy @ $3.67, valued at $6.4k
11/03/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $12.4, valued at $372k
11/03/2020 3 Duncan Barbara Gayle (Director) has filed a Form 3 on Fusion Pharmaceuticals Inc.
10/30/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 80,000 options to buy @ $24, valued at $1.9M
10/29/2020 3 Duncan Barbara Gayle (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc.
10/23/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 49,244 shares @ $0
Disposed/sold 6,540 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
09/16/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 5,000 shares @ $9.5, valued at $47.5k
Sold 5,000 shares @ $10.5, valued at $52.5k
Exercised 10,000 options to buy @ $4.21, valued at $42.1k
09/15/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Exercised 2,500 options to buy @ $16.96, valued at $42.4k
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4/A Duncan Barbara Gayle (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 15,700 options to buy @ $7.58, valued at $119k
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 13,550 options to buy @ $7.58, valued at $102.7k
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 13,250 options to buy @ $5.29, valued at $70.1k
02/05/2020 4 Duncan Barbara Gayle (Director) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns: Disposed/sold 59,524 shares @ $0
Disposed/sold 50,000 options to buy @ $1.55, valued at $77.5k
Disposed/sold 20,000 options to buy @ $1.32, valued at $26.4k
Disposed/sold 20,000 options to buy @ $4.83, valued at $96.6k
Disposed/sold 40,000 options to buy @ $8.09, valued at $323.6k
Disposed/sold 10,591 options to buy @ $2.84, valued at $30.1k
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2019 4/A Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.
Txns: Granted 5,813 options to buy @ $1.65, valued at $9.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy